Clinical Trials for Actuate Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Actuate Therapeutics

Clinical Trials (4)

NCT06896188
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
PHASE1Recruiting
12 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT05077800
FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer
PHASE2Active, not recruiting
70 participants
Started: Mar 21, 2022 · Completed: Jul 31, 2026
2 conditions3 sponsors3 locations
NCT05010629
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
PHASE2Active, not recruiting
35 participants
Started: Sep 14, 2021 · Completed: Apr 12, 2027
4 conditions2 sponsors2 locations
NCT03678883
9-ING-41 in Patients with Advanced Cancers
PHASE2Active, not recruiting
350 participants
Started: Jan 4, 2019 · Completed: Jan 31, 2026
25 conditions1 sponsor66 locations